Incident Report
Subform I: General Information
1. Report Type.
New incident report
Incident Report Number: 2010-5681
2. Registrant Information.
Registrant Reference Number: 110910-01 DTF
Registrant Name (Full Legal Name no abbreviations): Industry Task Force II on 2,4-D Research Data (members: Agro Gor Corporation, Dow AgroSciences LLC and Nufarm Americas, Inc.)
Address: 1900 K. St, NW
City: Washington
Prov / State: DC
Country: USA
Postal Code: 20006-1108
3. Select the appropriate subform(s) for the incident.
Scientific Study
4. Date registrant was first informed of the incident.
5. Location of incident.
6. Date incident was first observed.
Product Description
7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.
Active(s)
PMRA Registration No.
PMRA Submission No. 2002-0726
EPA Registration No.
Product Name: 2,4-D Acid
7. b) Type of formulation.
Application Information
8. Product was applied?
Unknown
9. Application Rate.
10. Site pesticide was applied to (select all that apply).
11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).
To be determined by Registrant
12. In your opinion, was the product used according to the label instructions?
Unknown
Subform VII: Scientific Study
1. Study Reference
Title 2,4-Dichlorophenoxyacetic acid: A Fish Short-Term Reproduction Assay using the Fathead Minnow, Pimephales promelas
Date 09-NOV-10
2. a) Is an extension needed to translate the document?
No
3. Type of incident identified in the study
Presence of a component or derivitive
4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)
The only significant effect observed in the study was a decrease in fecundity among minnows at the 96.5 mg/L level. See 6(a)(2) letter submitted to US EPA on November 9, 2010 for full explanation of the new information in the assay study.
5. a) Was the study discontinued before completion?
No
5. b) Provide the reason for discontinuation
6. If the study is ongoing, what is the expected completion date?
Unknown
For Registrant use only
7. Provide supplemental information here